Raised full-year 2026 revenue, adjusted EBITDA, and adjusted diluted EPS guidance after stronger organic growth and updated M&A/FX assumptions.
Large pharma clients are asking IQVIA to prepare thousands of FTEs as AI-driven discovery expands future study portfolios.
Pfizer regional promotion agreement covering selected products across 23 European countries.
Boehringer Ingelheim selected IQVIA’s Data-as-a-Service plus platform to harmonize global commercial operations and support upcoming launches.
iqvia.ai agentic AI portal and marketplace launched for life sciences clients.
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for IQVIA Holdings Inc. and 4,900+ companies.